Is there any association between manganese level and schizophrenia?- a descriptive review
DOI:
https://doi.org/10.2478/cpp-2020-0005Keywords:
schizophrenia,, manganese, MnAbstract
Introduction. Manganese has a role in the membrane transport systems, synthesis of protein, vitamin C, and vitamins B, catalysis of hematopoiesis, regulation of the endocrine, immune system, blood sugar, reproduction, digestion, and blood coagulation. Furthermore, the level of manganese concentrations in human body appears to affect the occurrence of schizophrenia. The aim of this study was to search for relationships between the manganese level and the onset of schizophrenia.
Material and methods. A descriptive review was performed based on a literature search on Medline and Google scholar from 2003 to 2020, using keywords: schizophrenia, manganese, Mn. The included studies were meta-analyses, case-control studies, and cohort studies that examined differences in manganese concentrations in patients with schizophrenia and healthy controls.
Result. Eight studies were selected for the review, with one reporting elevated levels of manganese, two showing no significant differences, and the rest including two meta-analyses stating lower manganese concentrations in patients with schizophrenia in comparison with controls.
Conclusion. In most of the researched studies, manganese concentrations in patients with schizophrenia were lower than in control groups, but not all of them reached the same conclusions. The relationship between manganese levels and schizophrenia must be further investigated.
References
1. Aschner JL, Aschner M. Nutritional aspects of manganese homeostasis. Mol Aspects Med. 2005;26(4-5):353-62.
2. Agency for Toxic Substances and Disease Registry. A Toxicological Profile for Manganese [Internet]. 2012 [cited 2020 Mar 22]. Available from: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=102&tid=23
3. Manganese. Fact Sheet for Health Professionals. [Internet]. National Institutes of Health. 2020 [cited 2020 Mar 16]. Available from: https://ods.od.nih.gov/factsheets/Manganese-HealthProfessional/
4. Freeland-Graves J, Mousa T, Kim S. International variability in diet and requirements of manganese: causes and consequences. J Trace Elem Med Biol. 2016;38:24-32.
5. Chen P, Chakraborty S, Mukhopadhyay S, Lee E, Paoliello MMB, Bowman AB, et al. Manganese homeostasis in the nervous system. J Neurochem. 2015;134(4):601-10.
6. Erikson KM, Aschner M. Manganese: its role in disease and health. Met Ions Life Sci. 2019;(19):253-66.
7. Horning KJ, Caito SW, Tipps KG, Bowman AB, Aschner M. Manganese is essential for neuronal health. Annu Rev Nutr. 2015;35:71-108.
8. Li L, Yang X. The essential element manganese, oxidative stress, and metabolic diseases: links and interactions. Oxid Med Cell Longev. 2018;2018:7580707-7580707.
9. Ye Q, Park JE, Gugnani K, Betharia S, Pino-Figueroa A, Kim J. Influence of iron metabolism on manganese transport and toxicity. Metallomics. 2017;9(8):1028-46.
10. Finley JW. Does environmental exposure to manganese pose a health risk to healthy adults. Nutr Rev. 2004;62(4):148-53.
11. Sidoryk-Wegrzynowicz M, Lee E, Albrecht J, Aschner M. Manganese disrupts astrocyte glutamine transporter expression and function. J Neurochem. 2009;110(3):822-30.
12. Saghazadeh A, Mahmoudi M, Shahrokhi S, Mojarrad M, Dastmardi M, Mirbeyk M, et al. Trace elements in schizophrenia: a systematic review and meta-analysis of 39 studies (N = 5151 participants). Nutr Rev. 2019;78(4):278-303.
13. Martinez-Finley E, Gavin C, Aschner M, Gunter T. Manganese neurotoxicity and the role of reactive oxygen species. Free Radic Biol Med. 2013;62:65-75.
14. Yanik M, Vural H, Kocyigit A, Tutkun H, Zoroglu S, Herken H, et al. Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology. 2003;47:61-5.
15. Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Letters. 2001 May 18;497(1):1-5.
16. Lehmann C, Bette S, Engele J. High extracellular glutamate modulates expression of glutamate transporters and glutamine synthetase in cultured astrocytes. Brain Res. 2009;(1297):1-8.
17. Morello M, Zatta P, Zambenedetti P, Martorana A, D’Angelo V, Melchiorri G, et al. Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. Brain Res Bull. 2007;74(6):406-15.
18. Steffek AE, McCullumsmith RE, Haroutunian V, Meador- Woodruff JH. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr Res. 2008; 103(1-3): 71-82.
19. Flatow J, Buckley P, Miller B. Meta-Analysis of Oxidative Stress in Schizophrenia. Biol Psychiatry, 2013;74(6):400-9.
20. Cao B, Yan L, Ma J, Min J, Park C, Nozari Y, et al. Comparison of serum essential trace metals between patients with schizophrenia and healthy controls. J Trace Elem Med Biol. 2019;51:79-85.
21. Yao J, Leonard S. Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr Bull. 2004;30:923-34.
22. Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H. Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res. 2004;98:109-17.
23. Liu T, Lu Q-B, Yan L, Guo J, Feng F, Qiu J, et al. Comparative study on serum levels of 10 trace elements in schizophrenia. PLoS One. 2015;10(7):e0133622-e0133622.
24. Rahman MdA, Azad MAK, Hossain MdI, Qusar MMAS, Bari W, Begum F, et al. Zinc, manganese, calcium, copper, and cadmium level in scalp hair samples of schizophrenic patients. Biol Trace Elem Res. 2009;127(2):102-8.
25. Nawaz R, Zahir E, Siddiqui S, Usmani A, Shad KF. The role of trace metals and environmental factors in the onset and progression of schizophrenia in pakistani population. World J Neurosci. 2014;4:450-60.
26. Kaya B, Akdaǧ N, Fadillioǧlu E, Taycan SE, Emre MH, Unal S, et al. Elements levels and glucose-6-phosphate dehydrogenase activity in blood of patients with schizophrenia. Dusunen Adam. 2012;25(3):198-205.
27. Arinola O, Idonije O. Status of plasma nitric oxide and nonenzymatic antioxidants before and after antipsychotic treatment in Nigerian patients with schizophrenia. J Res Med Sci. 2009;14(1):37-42.
28. Rivera-Mancía S, Colin-Ramirez E, Montes S, Cartas R, Vargas- Barrón J, Vallejo M. Dyslipidemia and tobacco smoking synergistically increase serum manganese. Investigación clínica. 2017;58:238-49.
29. Grochowski C, Blicharska E, Baj J, Mierzwińska A, Brzozowska K, Forma A, et al. Serum iron, magnesium, copper, and manganese levels in alcoholism: a systematic review. Molecules, 2019;24:1361.
30. Scassellati C, Bonvicini C, Benussi L, Ghidoni R, Squitti R. Neurodevelopmental disorders: metallomics studies for the identification of potential biomarkers associated to diagnosis and treatment. J Trace Elem Med Biol. 2020;(60):126499.
31. Frisbie SH, Mitchell EJ, Dustin H, Maynard DM, Sarkar B. World Health Organization discontinues its drinking-water guideline for manganese. Environ Health Perspect. 2012;120(6):775-8.
32. Dobson A, Erikson K, Aschner M. Manganese neurotoxicity. Ann N Y Acad Sci. 2004;1012:115-28.
33. Erikson KM, Dorman DC, Lash LH, Aschner M. Manganese Inhalation by Rhesus Monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol Sci. 2007 Mar 7;97(2):459-66.
34. Peres TV, Schettinger MRC, Chen P, Carvalho F, Avila DS, Bowman AB, et al. Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies. BMC Pharmacol Toxicol. 2016;17(1):57-57.
35. Firth J, Carney R, Stubbs B, Teasdale SB, Vancampfort D, Ward PB, et al. Nutritional deficiencies and clinical correlates in firstepisode psychosis: a systematic review and meta-analysis. Schizophr Bull. 2017;44(6):1275-92.
36. Wang D-F, Cao B, Xu M-Y, Liu Y-Q, Yan L-L, Liu R, et al. Meta- Analyses of manganese superoxide dismutase activity, gene Ala- 9Val polymorphism, and the risk of schizophrenia. Medicine. 2015;94(36):e1507.
37. Zhang X, Zhou D, Shen Y, Zhang P, Zhang W, Liang J, et al. Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia. Neuropharmacology. 2012;62:1928-34.
38. Wu J, Kosten T, Zhang X. Free radicals, antioxidant defense systems, and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 2013;46:200-6.
39. Miljević ČD, Nikolić-Kokić A, Blagojević D, Milovanović M, Munjiza A,Marin M Jukić MM, et al. Association between soft neurological signs and antioxidant enzyme activity in schizophrenic patients. Psychiatry Res. 2018;269:746-52.
40. Liu P, Jing Y, Collie ND, Dean B, Bilkey DK, Zhang H. Altered brain arginine metabolism in schizophrenia. Transl Psychiatry, 2016;6(8):e871-e871.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
